Charles River Labs (CRL) PT Raised to $322 at RBC Capital

September 25, 2026 8:36 AM

RBC Capital analyst Ryan Halsted raised the price target on Charles River Labs (NYSE: CRL) to $322.00 (from $282.00) while maintaining a Outperform rating.

No results found